Holdings Channel Holdings Channel 13F research and institutional holdings

SNSE Insider Buying

The table below summarizes the most recent SNSE insider buying information — the latest buy being $425.00 by John Celebi on 9/11/2023, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why SNSE insider buys like these are important for investors to follow.
SNSE insider buying image
DateInsiderPriceAmount
9-11-2023
Insider Buy		 John Celebi
President and CEO		 $0.85
CAGR » 		$425.00
500 shares
2-23-2023
Insider Buy		 Investment Group LTD. Apeiron
>10% Owner		 $1.61
CAGR » 		$3,539.03
2,200 shares
3-2-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $3.20
CAGR » 		$3,849.60
1,203 shares
2-24-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $3.65
CAGR » 		$63,950.00
17,500 shares
2-18-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.02
CAGR » 		$80,187.33
19,949 shares
2-18-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.02
CAGR » 		$80,187.33
19,949 shares
2-16-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.19
CAGR » 		$52,641.75
12,551 shares
2-16-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.19
CAGR » 		$52,641.75
12,551 shares
2-8-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.53
CAGR » 		$135,800.00
30,000 shares
2-8-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.53
CAGR » 		$135,800.00
30,000 shares
1-28-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.26
CAGR » 		$63,849.00
15,000 shares
1-28-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.26
CAGR » 		$63,849.00
15,000 shares
1-26-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.72
CAGR » 		$235,824.00
50,000 shares
1-26-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.72
CAGR » 		$235,824.00
50,000 shares
1-24-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.82
CAGR » 		$228,528.65
47,410 shares
1-24-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $4.82
CAGR » 		$228,528.65
47,410 shares
1-20-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.10
CAGR » 		$154,312.68
30,244 shares
1-20-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $5.10
CAGR » 		$154,312.68
30,244 shares
1-18-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.08
CAGR » 		$50,800.00
10,000 shares
1-18-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $5.08
CAGR » 		$50,800.00
10,000 shares
1-14-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.10
CAGR » 		$133,391.70
26,172 shares
1-14-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $5.10
CAGR » 		$133,391.70
26,172 shares
1-12-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.20
CAGR » 		$104,211.54
20,047 shares
1-12-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $5.20
CAGR » 		$104,211.54
20,047 shares
1-10-2022
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.28
CAGR » 		$52,800.00
10,000 shares
1-10-2022
Insider Buy		 James Peyer
Director and >10% Owner		 $5.28
CAGR » 		$52,800.00
10,000 shares
12-30-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.85
CAGR » 		$5,465.95
1,127 shares
12-30-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $4.85
CAGR » 		$5,465.95
1,127 shares
12-29-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $4.98
CAGR » 		$343,620.00
69,000 shares
12-29-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $4.98
CAGR » 		$343,620.00
69,000 shares
12-28-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $5.28
CAGR » 		$59,600.64
11,288 shares
12-28-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.28
CAGR » 		$59,600.64
11,288 shares
12-27-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.30
CAGR » 		$19,673.60
3,712 shares
12-27-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $5.30
CAGR » 		$19,673.60
3,712 shares
12-23-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.27
CAGR » 		$57,970.00
11,000 shares
12-23-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $5.27
CAGR » 		$57,970.00
11,000 shares
12-16-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $5.25
CAGR » 		$57,356.25
10,925 shares
12-10-2021
Insider Buy		 Thomas G. Ricks
Director		 $6.24
CAGR » 		$249,600.00
40,000 shares
5-5-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $12.00
CAGR » 		$4,200.00
350 shares
4-20-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $12.77
CAGR » 		$4,916.45
385 shares
4-20-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $12.77
CAGR » 		$4,916.45
385 shares
4-19-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $13.38
CAGR » 		$26,291.70
1,965 shares
4-19-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $13.38
CAGR » 		$26,291.70
1,965 shares
4-13-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $14.00
CAGR » 		$28,000.00
2,000 shares
4-13-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $14.00
CAGR » 		$28,000.00
2,000 shares
4-7-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $14.00
CAGR » 		$28,000.00
2,000 shares
4-1-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $14.00
CAGR » 		$14,000.00
1,000 shares
4-1-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $14.00
CAGR » 		$14,000.00
1,000 shares
3-30-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $12.00
CAGR » 		$24,000.00
2,000 shares
3-30-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $12.00
CAGR » 		$24,000.00
2,000 shares
3-24-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $14.12
CAGR » 		$52,950.00
3,750 shares
3-24-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $14.12
CAGR » 		$52,950.00
3,750 shares
3-22-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $15.02
CAGR » 		$32,788.66
2,183 shares
3-22-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $15.02
CAGR » 		$32,788.66
2,183 shares
3-18-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $15.25
CAGR » 		$12,459.25
817 shares
3-8-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $15.25
CAGR » 		$15,249.00
1,000 shares
3-8-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $15.25
CAGR » 		$15,249.00
1,000 shares
3-4-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $15.16
CAGR » 		$75,800.00
5,000 shares
3-4-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $15.16
CAGR » 		$75,800.00
5,000 shares
2-26-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $16.25
CAGR » 		$81,250.00
5,000 shares
2-22-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $18.88
CAGR » 		$185,061.76
9,802 shares
2-22-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $18.88
CAGR » 		$185,061.76
9,802 shares
2-18-2021
Insider Buy		 James Peyer
Director and >10% Owner		 $19.75
CAGR » 		$14,871.75
753 shares
2-18-2021
Insider Buy		 Biopharma Inc Cambrian
>10% Owner		 $19.75
CAGR » 		$14,871.75
753 shares

Also See: Institutional Holders of SNSE
Also See: SEC filings


SNSE Insider Purchase CAGR Analysis

SNSE Performance Since Insider Purchase
Below we present the annualized performance delivered by SNSE stock since 9-11-2023 (the date of the most recent insider purchase). The performance of the investment from the time SNSE insider buying occurred is the ultimate test of whether insiders were right about SNSE being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 09/12/2023
End date: 05/19/2026
Start price/share: $15.60
End price/share: $16.77
Dividends collected/share: $0.00
Total return: 7.50%
Average Annual Total Return: 2.73%
Starting investment: $10,000.00
Ending investment: $10,749.95
Years: 2.68

Which SNSE Insiders Report Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent SNSE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding SNSE
SNSE — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree SNSE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

SNSE — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the SNSE Insider Buying occurred are:

RGR Insider Buying
HDSN Insider Buying
TFSL Insider Buying
TONX Insider Buying
NSPR Insider Buying
VTSI Insider Buying
EQPT Insider Buying
TXO Insider Buying
ULS Insider Buying
XRN Insider Buying

SNSE Insider Buying: Recent SNSE Purchases by Company Insiders | www.HoldingsChannel.com | Copyright © 2013 - 2026, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Holdings Channel is not affiliated with, endorsed by, or sponsored by any investment manager listed on this site. Company, fund, ETF, and investment manager names are used for identification and informational purposes only. Holdings data is based on publicly available regulatory filings and other market data sources. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.